Just thought I´d post this. I saw it on FB. Please read below.
Russia has made a groundbreaking announcement in the field of cancer treatment, unveiling its first mRNA-based cancer vaccine, which is expected to be publicly available by early 2025. This innovative development represents a major advancement in oncology, as it shifts the focus from traditional preventive vaccines to an advanced therapeutic approach designed to treat patients already diagnosed with cancer. Unlike conventional treatments such as chemotherapy and radiation, this next-generation cancer vaccine harnesses the power of mRNA technology to stimulate the body’s immune system, targeting and destroying cancer cells with precision.
Andrey Kaprin, head of the Radiology Medical Research Center in Russia, has confirmed that the vaccine will be provided free of charge, ensuring widespread accessibility to this life-saving breakthrough. This initiative reflects Russia’s commitment to making cutting-edge cancer treatments available to a larger population, eliminating financial barriers to advanced healthcare solutions.
Early clinical trials have yielded highly promising results, demonstrating that the vaccine can effectively slow down tumor progression and prevent malignant cells from metastasizing. The integration of artificial intelligence in healthcare has further enhanced the vaccine’s capabilities, with Alexander Gintsburg, director of the Gamaleya National Research Center, revealing that AI-driven technology enables rapid customization of the vaccine for individual patients in less than an hour. This revolutionary approach to personalized medicine optimizes treatment efficacy by tailoring immunotherapy to the genetic profile of each patient’s cancer, significantly improving patient outcomes.
While this breakthrough marks a transformative milestone in modern oncology, some key details remain undisclosed, including the specific types of cancer the vaccine will target and its official medical designation. Russia’s pioneering achievement positions it alongside global leaders such as the United States and Germany, who are also accelerating advancements in personalized cancer immunotherapy using mRNA technology. If successfully implemented on a large scale, this game-changing cancer vaccine has the potential to revolutionize the global healthcare industry, redefining cancer treatment protocols and offering renewed hope to millions of patients battling this life-threatening disease.
Last autumn, around December 2024, Russia announced the development of a personalized mRNA-based cancer vaccine, generating significant interest worldwide. This vaccine is designed to be tailored to individual patients by analyzing the genetic makeup of their tumors to identify specific mutations, known as neoantigens. The idea is to train the immune system to recognize and attack cancer cells based on these unique markers. Russian state media reported that the vaccine demonstrated promising results in pre-clinical trials, suppressing tumor growth and preventing metastasis—the spread of cancer to other parts of the body. It’s being developed by a trio of institutes, including the Gamaleya National Research Center, which previously created the Sputnik V COVID-19 vaccine. The plan is to roll it out free of charge to eligible cancer patients in Russia starting early 2025.
That said, details remain sparse. Russian officials, including President Vladimir Putin, who first hinted at this breakthrough in February 2024, have touted it as a major advancement. Yet, specifics—such as which cancers it targets, the stages of cancer it’s intended for, or the full scope of trial data—haven’t been widely disclosed. Reports suggest it’s not a preventative vaccine for healthy people but a treatment for those already diagnosed, possibly focusing on terminally ill patients. The lack of transparent data has fueled skepticism among experts outside Russia. They point to past concerns with Russian vaccine claims, like Sputnik V, where questions about data integrity and rushed timelines surfaced. Without peer-reviewed studies or detailed methodologies, it’s hard to gauge its efficacy or safety compared to other mRNA cancer vaccines in development globally, like those from Moderna or BioNTech.
For context, mRNA cancer vaccines aren’t a new concept—research has been ongoing for years, with 2024 dubbed by some as a breakthrough year for the field. The Russian effort seems to align with this trend, leveraging AI and genetic sequencing to personalize treatment, a process that could take months per patient. However, experts caution against overhype. Cancer is incredibly diverse, and a one-size-fits-all solution is unlikely—success would depend on targeting specific mutations in specific cancer types. Until Russia releases more concrete evidence, the announcement remains a bold claim with potential, but it’s too early to call it a game-changer. Keep an eye out for updates in early 2025 when it’s supposedly set to launch—that’s when we might get a clearer picture.
Yeah I agree with all of that too. I'm just taking a glass half full approach to it all because true or not it may kick big pharma into accelerating whatever they're intending to do. I have got big hopes when considering AI in all of this. I'm not hopping that tomorrow we'll all be cured but I would hope that within 5 years something must give....
There are a few sides to Russian medical research. First, yes they are known for a bit of puffery to put it lightly. But, they also don’t get credit for some really novel research. Part if it is because they don’t follow all the protocols that other countries do - such as animal testing which is a subject for another day - but can result in some interesting discoveries. I hang out with researchers who have given me some interesting insights about foreign research. Anyways, there is good news on the horizon for all cancer sufferers including mRNA. The challenges with mRNA is that it is sort of lock and key meaning that they do testing to match the DNA of the cancer to the mRNA therapy. Why? Because prostate cancer, when advanced, has many cell lines i.e. heterogenous. Not insurmountable but matching many types is an issue. Also, this is a type of immunotherapy which is also a PCa challenge since PCa doesn’t have many T cell receptors. This may all still work but it may take more time and may be most applicable to early cases. But don’t despair since Betamax looks like garbage versus today’s streaming and innovation happens at a much faster pace nowadays. I am just so happy we are exploring options to ADT, radiation and chemo. I like others, will be watching with hopeful anticipation. Some peptide therapies may also be a gamechanger.
Let's hope we have some exciting and positive times ahead. Right now though I'm just battling yet another hot flush as I'm writing to you🥵.I really hope that one day all those intelligent young talents around the world will solve this problem for us all.
Thanks for sharing this! I was skeptical as anytime I see "Russia" and "Facebook" in the same sentence I walk away. I did a quick search and Russia DID announce it (not just a FB thing) and some other countries talked about it. If true, it sure would WRECK the U.S. cancer medical profits. Most are skeptical as like with China, Russia's clinical trials are considered not scientific rigorous. I'm going to watch this though. Thx a lot for sharing here.
It would only wreck the US cancer treatment profits IF there was one vaccine that killed ALL cancers - and we know that isn't going to happen. This research has been ongoing for probably over a decade in the US, and is being used on some cancers (melanoma is one that comes to mind.) As MelodyCat pointed out - the vaccines currently have to be matched not only to the patient, but also to the patient's cancer, which may not be a simple cancer... it would be a breakthrough IF the Russians managed to get around that issue, but somehow from reading the report - it sounds like a rehash of some US papers I read several years ago on mRNA treatment.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Ranolazine (used for angina) could potentially be repurposed for PCa. Only mouse studies so far. 
We might for the first time really be thinking of cures of cancer’
LDN and Cancer
